Taysha Gene Therapies, Inc.

NASDAQ:TSHA

2.15 (USD) • At close September 18, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q4
Omzet 1.1123.4113.6044.7462.3954.7062.502000000000000
Kosten van de omzet 0.30.3250.3660.3310.7030.6311.6790.30.30.2570.2090.1660.0850.03200000
Brutowinst 0.8123.0863.2384.4151.6924.0750.823-0.3-0.3-0.257-0.209-0.166-0.085-0.03200000
Brutowinstmarge 0.730.9050.8980.930.7060.8660.329000000000000
Onderzoek- en ontwikkelingskosten 15.07320.65712.68211.79119.79112.51413.86116.39123.11837.79937.91839.52830.64323.85412.2611.0573.0625.5140.987
Algemene en administratieve kosten 7.3387.0846.7198.5895.9888.7517.3418.6839.86711.46911.80611.15310.1298.2366.1073.9840.9480.070.128
Verkoop- en marketingkosten -0.3-0.325-0.3660000000000000000
Verkoop-, algemene en administratieve kosten 7.0386.7596.3538.5895.9888.7517.3418.6839.86711.46911.80611.15310.1298.2366.1073.9840.9480.070.128
Overige kosten -1.237-1.058-1.5610.6160.003-0.008-0.006-0.001-0.003-0.008000017.030-17.210.180
Bedrijfskosten 22.11127.41619.03520.99625.77921.26521.20225.07432.98549.26849.72450.68140.77232.0918.36715.0414.015.5841.115
Bedrijfsresultaat -21.299-24.33-15.797-16.25-23.384-16.559-55.12-25.074-32.985-49.268-49.724-50.681-40.772-32.09-18.367-15.041-4.01-5.584-1.115
Bedrijfsresultaat ratio -19.154-7.133-4.383-3.424-9.764-3.519-22.03000000000000
Totaal overige inkomsten en kosten netto 0.3710.26963.538-100.8370.003-1.063-0.603-1.233-0.888-0.843-0.691-0.506-0.1540.0660.049-0.001-17.210.18-1.115
Inkomen voor belasting -20.928-24.06147.741-117.087-24.598-17.622-55.723-26.307-33.873-50.111-50.386-51.187-40.926-32.024-18.318-15.042-21.22-5.431-1.115
Inkomen voor belasting ratio -18.82-7.05413.247-24.671-10.271-3.745-22.271000000000000
Belastingkosten 00.282-3.549-0.3311.4432.4372.3341.2330.8880.8430.6910.0370.040.0660.049-0.003-21.220.027-1.161
Nettowinst -20.928-24.06147.741-117.087-24.598-20.059-58.057-27.54-34.761-50.954-50.386-51.187-40.926-32.024-18.318-15.042-21.22-5.431-1.115
Nettowinstmarge -18.82-7.05413.247-24.671-10.271-4.262-23.204000000000000
WPA (Winst Per Aandeel) -0.09-0.10.26-0.93-0.38-0.32-1.03-0.67-0.87-1.33-1.32-1.35-1.09-0.87-1.04-1.28-0.61-0.36-0.074
Verwaterde WPA -0.09-0.10.26-0.93-0.38-0.32-1.03-0.67-0.87-1.33-1.32-1.35-1.09-0.87-1.04-1.28-0.61-0.36-0.074
EBITDA -20.999-24.005-15.431-16.25-22.815-15.917-18.507-24.789-32.687-49.005-49.695-50.478-40.647-31.992-18.312-15.041-21.22-5.404-1.115
EBITDA ratio -18.884-7.038-4.282-3.424-9.526-3.382-7.397000000000000